546
Views
11
CrossRef citations to date
0
Altmetric
Review

Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application

&
Pages 845-854 | Received 04 Mar 2019, Accepted 30 Apr 2019, Published online: 13 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hong-My Nguyen & Dipongkor Saha. (2021) The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment. Oncolytic Virotherapy 10, pages 1-27.
Read now

Articles from other publishers (10)

Tanvir Ahmed. (2023) Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme. MedComm – Oncology 2:1.
Crossref
Irene Appolloni, Francesco Alessandrini, Laura Menotti, Elisa Avitabile, Daniela Marubbi, Noemi Piga, Davide Ceresa, Francesca Piaggio, Gabriella Campadelli-Fiume & Paolo Malatesta. (2021) Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma. Viruses 13:9, pages 1677.
Crossref
A.B. Carpenter, A.M. Carpenter, R. Aiken & S. Hanft. (2021) Oncolytic virus in gliomas: a review of human clinical investigations. Annals of Oncology 32:8, pages 968-982.
Crossref
Benjamin B. Kasten, Hailey A. Houson, Jennifer M. Coleman, Jianmei W. Leavenworth, James M. Markert, Anna M. Wu, Felix Salazar, Richard Tavaré, Adriana V. F. Massicano, G. Yancey Gillespie, Suzanne E. Lapi, Jason M. Warram & Anna G. Sorace. (2021) Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model. Scientific Reports 11:1.
Crossref
Ni Tong, Zhenqiang He, Yujie Ma, Zheng Wang, Ziming Huang, Haihong Cao, Lanyang Xu, Yuheng Zou, Wanyu Wang, Chenpeng Yi, Zhixin Yin & Qirui Wang. (2021) Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?. Frontiers in Cell and Developmental Biology 9.
Crossref
Norah Aldrak, Sarah Alsaab, Aliyah Algethami, Deepak Bhere, Hiroaki Wakimoto, Khalid Shah, Mohammad N. Alomary & Nada Zaidan. (2021) Oncolytic Herpes Simplex Virus-Based Therapies for Cancer. Cells 10:6, pages 1541.
Crossref
Micheli Mainardi Pillat, Ágatha Oliveira‐Giacomelli, Mona Neves Oliveira, Roberta Andrejew, Natalia Turrini, Juliana Baranova, Tamara Lah Turnšek & Henning Ulrich. (2021) Mesenchymal stem cell‐glioblastoma interactions mediated via kinin receptors unveiled by cytometry. Cytometry Part A 99:2, pages 152-163.
Crossref
Ming Li, Guoping Li, Juri Kiyokawa, Zain Tirmizi, Leland G. Richardson, Jianfang Ning, Saumya Das, Robert L. Martuza, Anat Stemmer-Rachamimov, Samuel D. Rabkin & Hiroaki Wakimoto. (2020) Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma. Acta Neuropathologica Communications 8:1.
Crossref
Zhi‐Qiang Ye, Chang‐Lin Zou, Han‐Bin Chen, Qi‐Yuan Lv, Ruo‐Qi Wu & Dian‐Na Gu. (2020) Folate‐conjugated herpes simplex virus for retargeting to tumor cells. The Journal of Gene Medicine 22:7.
Crossref
Jianfang Ning & Hiroaki Wakimoto. (2020) Therapeutic Application of PARP Inhibitors in Neuro-Oncology. Trends in Cancer 6:2, pages 147-159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.